<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Wed, 24 Jun 2026 05:06:00 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Tecan Accelerates Data-Driven Lab Journey With Agentic AI Developments Powered by NVIDIA</title>
   <link>http://www.streetinsider.com/Press+Releases/Tecan+Accelerates+Data-Driven+Lab+Journey+With+Agentic+AI+Developments+Powered+by+NVIDIA/26681510.html</link>
   <description>
&lt;p&gt;    MÄNNEDORF, Switzerland--(BUSINESS WIRE)--
Tecan (SIX Swiss Exchange: TECN), a global provider of laboratory automation and solutions, today announced the integration of Agentic AI capabilities into its lab analytics platform Introspect, leveraging &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fgithub.com%2FNVIDIA-BioNeMo%2Fbionemo-agent-toolkit&amp;amp;esheet=54559575&amp;amp;newsitemid=20260624334317&amp;amp;lan=en-US&amp;amp;anchor=NVIDIA+BioNeMo+Agent+Toolkit&amp;amp;index=1&amp;amp;md5=61829adb5ccc02b14c9607f7b93e950a&quot; shape=&quot;rect&quot;&gt;NVIDIA BioNeMo Agent Toolkit&lt;/a&gt;. The NVIDIA BioNeMo Agent Toolkit enables AI agents to access scientific AI capabilities directly within the Introspect platform, helping laboratories to optimize operations. Agentic AI will allow laboratories to move beyond traditional monitoring and reactive troubleshooting toward proactive actions that help prevent issues before they impact performance, quality, or scientific outcomes. Early access to the enhanced Introspect platform</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Tecan+Accelerates+Data-Driven+Lab+Journey+With+Agentic+AI+Developments+Powered+by+NVIDIA/26681510.html</guid>
   <pubDate>Wed, 24 Jun 2026 05:06:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.00222376</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TCGGY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TECN</category>
   	  </item>
  <item>
   <title>Tecan Accelerates Data-Driven Lab Journey With Agentic AI Developments Powered by NVIDIA</title>
   <link>http://www.streetinsider.com/Press+Releases/Tecan+Accelerates+Data-Driven+Lab+Journey+With+Agentic+AI+Developments+Powered+by+NVIDIA/26681510.html</link>
   <description>
&lt;p&gt;    MÄNNEDORF, Switzerland--(BUSINESS WIRE)--
Tecan (SIX Swiss Exchange: TECN), a global provider of laboratory automation and solutions, today announced the integration of Agentic AI capabilities into its lab analytics platform Introspect, leveraging &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fgithub.com%2FNVIDIA-BioNeMo%2Fbionemo-agent-toolkit&amp;amp;esheet=54559575&amp;amp;newsitemid=20260624334317&amp;amp;lan=en-US&amp;amp;anchor=NVIDIA+BioNeMo+Agent+Toolkit&amp;amp;index=1&amp;amp;md5=61829adb5ccc02b14c9607f7b93e950a&quot; shape=&quot;rect&quot;&gt;NVIDIA BioNeMo Agent Toolkit&lt;/a&gt;. The NVIDIA BioNeMo Agent Toolkit enables AI agents to access scientific AI capabilities directly within the Introspect platform, helping laboratories to optimize operations. Agentic AI will allow laboratories to move beyond traditional monitoring and reactive troubleshooting toward proactive actions that help prevent issues before they impact performance, quality, or scientific outcomes. Early access to the enhanced Introspect platform</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Tecan+Accelerates+Data-Driven+Lab+Journey+With+Agentic+AI+Developments+Powered+by+NVIDIA/26681510.html</guid>
   <pubDate>Wed, 24 Jun 2026 05:06:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.00222376</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TCGGY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TECN</category>
   	  </item>
  <item>
   <title>Tecan Accelerates Data-Driven Lab Journey With Agentic AI Developments Powered by NVIDIA</title>
   <link>http://www.streetinsider.com/Press+Releases/Tecan+Accelerates+Data-Driven+Lab+Journey+With+Agentic+AI+Developments+Powered+by+NVIDIA/26681510.html</link>
   <description>
&lt;p&gt;    MÄNNEDORF, Switzerland--(BUSINESS WIRE)--
Tecan (SIX Swiss Exchange: TECN), a global provider of laboratory automation and solutions, today announced the integration of Agentic AI capabilities into its lab analytics platform Introspect, leveraging &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fgithub.com%2FNVIDIA-BioNeMo%2Fbionemo-agent-toolkit&amp;amp;esheet=54559575&amp;amp;newsitemid=20260624334317&amp;amp;lan=en-US&amp;amp;anchor=NVIDIA+BioNeMo+Agent+Toolkit&amp;amp;index=1&amp;amp;md5=61829adb5ccc02b14c9607f7b93e950a&quot; shape=&quot;rect&quot;&gt;NVIDIA BioNeMo Agent Toolkit&lt;/a&gt;. The NVIDIA BioNeMo Agent Toolkit enables AI agents to access scientific AI capabilities directly within the Introspect platform, helping laboratories to optimize operations. Agentic AI will allow laboratories to move beyond traditional monitoring and reactive troubleshooting toward proactive actions that help prevent issues before they impact performance, quality, or scientific outcomes. Early access to the enhanced Introspect platform</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Tecan+Accelerates+Data-Driven+Lab+Journey+With+Agentic+AI+Developments+Powered+by+NVIDIA/26681510.html</guid>
   <pubDate>Wed, 24 Jun 2026 05:06:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.00222376</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TCGGY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TECN</category>
   	  </item>
  <item>
   <title>Tecan Accelerates Data-Driven Lab Journey With Agentic AI Developments Powered by NVIDIA</title>
   <link>http://www.streetinsider.com/Business+Wire/Tecan+Accelerates+Data-Driven+Lab+Journey+With+Agentic+AI+Developments+Powered+by+NVIDIA/26681510.html</link>
   <description>
&lt;p&gt;    MÄNNEDORF, Switzerland--(BUSINESS WIRE)--
Tecan (SIX Swiss Exchange: TECN), a global provider of laboratory automation and solutions, today announced the integration of Agentic AI capabilities into its lab analytics platform Introspect, leveraging &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fgithub.com%2FNVIDIA-BioNeMo%2Fbionemo-agent-toolkit&amp;amp;esheet=54559575&amp;amp;newsitemid=20260624334317&amp;amp;lan=en-US&amp;amp;anchor=NVIDIA+BioNeMo+Agent+Toolkit&amp;amp;index=1&amp;amp;md5=61829adb5ccc02b14c9607f7b93e950a&quot; shape=&quot;rect&quot;&gt;NVIDIA BioNeMo Agent Toolkit&lt;/a&gt;. The NVIDIA BioNeMo Agent Toolkit enables AI agents to access scientific AI capabilities directly within the Introspect platform, helping laboratories to optimize operations. Agentic AI will allow laboratories to move beyond traditional monitoring and reactive troubleshooting toward proactive actions that help prevent issues before they impact performance, quality, or scientific outcomes. Early access to the enhanced Introspect platform</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Tecan+Accelerates+Data-Driven+Lab+Journey+With+Agentic+AI+Developments+Powered+by+NVIDIA/26681510.html</guid>
   <pubDate>Wed, 24 Jun 2026 05:06:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.00222376</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TCGGY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TECN</category>
   	  </item>
  <item>
   <title>Tecan Accelerates Data-Driven Lab Journey With Agentic AI Developments Powered by NVIDIA</title>
   <link>http://www.streetinsider.com/Business+Wire/Tecan+Accelerates+Data-Driven+Lab+Journey+With+Agentic+AI+Developments+Powered+by+NVIDIA/26681510.html</link>
   <description>
&lt;p&gt;    MÄNNEDORF, Switzerland--(BUSINESS WIRE)--
Tecan (SIX Swiss Exchange: TECN), a global provider of laboratory automation and solutions, today announced the integration of Agentic AI capabilities into its lab analytics platform Introspect, leveraging &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fgithub.com%2FNVIDIA-BioNeMo%2Fbionemo-agent-toolkit&amp;amp;esheet=54559575&amp;amp;newsitemid=20260624334317&amp;amp;lan=en-US&amp;amp;anchor=NVIDIA+BioNeMo+Agent+Toolkit&amp;amp;index=1&amp;amp;md5=61829adb5ccc02b14c9607f7b93e950a&quot; shape=&quot;rect&quot;&gt;NVIDIA BioNeMo Agent Toolkit&lt;/a&gt;. The NVIDIA BioNeMo Agent Toolkit enables AI agents to access scientific AI capabilities directly within the Introspect platform, helping laboratories to optimize operations. Agentic AI will allow laboratories to move beyond traditional monitoring and reactive troubleshooting toward proactive actions that help prevent issues before they impact performance, quality, or scientific outcomes. Early access to the enhanced Introspect platform</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Tecan+Accelerates+Data-Driven+Lab+Journey+With+Agentic+AI+Developments+Powered+by+NVIDIA/26681510.html</guid>
   <pubDate>Wed, 24 Jun 2026 05:06:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.00222376</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TCGGY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TECN</category>
   	  </item>
  <item>
   <title>Tecan Accelerates Data-Driven Lab Journey With Agentic AI Developments Powered by NVIDIA</title>
   <link>http://www.streetinsider.com/Business+Wire/Tecan+Accelerates+Data-Driven+Lab+Journey+With+Agentic+AI+Developments+Powered+by+NVIDIA/26681510.html</link>
   <description>
&lt;p&gt;    MÄNNEDORF, Switzerland--(BUSINESS WIRE)--
Tecan (SIX Swiss Exchange: TECN), a global provider of laboratory automation and solutions, today announced the integration of Agentic AI capabilities into its lab analytics platform Introspect, leveraging &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fgithub.com%2FNVIDIA-BioNeMo%2Fbionemo-agent-toolkit&amp;amp;esheet=54559575&amp;amp;newsitemid=20260624334317&amp;amp;lan=en-US&amp;amp;anchor=NVIDIA+BioNeMo+Agent+Toolkit&amp;amp;index=1&amp;amp;md5=61829adb5ccc02b14c9607f7b93e950a&quot; shape=&quot;rect&quot;&gt;NVIDIA BioNeMo Agent Toolkit&lt;/a&gt;. The NVIDIA BioNeMo Agent Toolkit enables AI agents to access scientific AI capabilities directly within the Introspect platform, helping laboratories to optimize operations. Agentic AI will allow laboratories to move beyond traditional monitoring and reactive troubleshooting toward proactive actions that help prevent issues before they impact performance, quality, or scientific outcomes. Early access to the enhanced Introspect platform</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Tecan+Accelerates+Data-Driven+Lab+Journey+With+Agentic+AI+Developments+Powered+by+NVIDIA/26681510.html</guid>
   <pubDate>Wed, 24 Jun 2026 05:06:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.00222376</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TCGGY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TECN</category>
   	  </item>
  <item>
   <title>Tecan Establishes Direct Sales and Specialist Lab Automation Service Operations in India</title>
   <link>http://www.streetinsider.com/Press+Releases/Tecan+Establishes+Direct+Sales+and+Specialist+Lab+Automation+Service+Operations+in+India/26545019.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;
&lt;i&gt;Strengthening local presence and customer support in a high-growth life sciences market&lt;/i&gt;

&lt;/p&gt;
&lt;p&gt;    MÄNNEDORF, Switzerland--(BUSINESS WIRE)--
Tecan (SIX Swiss Exchange: TECN), a global provider of laboratory automation and solutions, today announced the launch of direct operations in India, including a dedicated local sales and service team based in Gurugram, near New Delhi. The launch, marked with a ribbon-cutting ceremony, is an important milestone in the company’s geographical expansion and reinforces its commitment to serving customers in one of the world’s most dynamic and fastest-growing life sciences markets.

&lt;/p&gt;&lt;p&gt;
For over a decade, Tecan has supported customers in India through its</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Tecan+Establishes+Direct+Sales+and+Specialist+Lab+Automation+Service+Operations+in+India/26545019.html</guid>
   <pubDate>Tue, 26 May 2026 05:43:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.00222376</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TCGGY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TECN</category>
   	  </item>
  <item>
   <title>Tecan Establishes Direct Sales and Specialist Lab Automation Service Operations in India</title>
   <link>http://www.streetinsider.com/Press+Releases/Tecan+Establishes+Direct+Sales+and+Specialist+Lab+Automation+Service+Operations+in+India/26545019.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;
&lt;i&gt;Strengthening local presence and customer support in a high-growth life sciences market&lt;/i&gt;

&lt;/p&gt;
&lt;p&gt;    MÄNNEDORF, Switzerland--(BUSINESS WIRE)--
Tecan (SIX Swiss Exchange: TECN), a global provider of laboratory automation and solutions, today announced the launch of direct operations in India, including a dedicated local sales and service team based in Gurugram, near New Delhi. The launch, marked with a ribbon-cutting ceremony, is an important milestone in the company’s geographical expansion and reinforces its commitment to serving customers in one of the world’s most dynamic and fastest-growing life sciences markets.

&lt;/p&gt;&lt;p&gt;
For over a decade, Tecan has supported customers in India through its</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Tecan+Establishes+Direct+Sales+and+Specialist+Lab+Automation+Service+Operations+in+India/26545019.html</guid>
   <pubDate>Tue, 26 May 2026 05:43:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.00222376</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TCGGY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TECN</category>
   	  </item>
  <item>
   <title>Tecan Establishes Direct Sales and Specialist Lab Automation Service Operations in India</title>
   <link>http://www.streetinsider.com/Press+Releases/Tecan+Establishes+Direct+Sales+and+Specialist+Lab+Automation+Service+Operations+in+India/26545019.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;
&lt;i&gt;Strengthening local presence and customer support in a high-growth life sciences market&lt;/i&gt;

&lt;/p&gt;
&lt;p&gt;    MÄNNEDORF, Switzerland--(BUSINESS WIRE)--
Tecan (SIX Swiss Exchange: TECN), a global provider of laboratory automation and solutions, today announced the launch of direct operations in India, including a dedicated local sales and service team based in Gurugram, near New Delhi. The launch, marked with a ribbon-cutting ceremony, is an important milestone in the company’s geographical expansion and reinforces its commitment to serving customers in one of the world’s most dynamic and fastest-growing life sciences markets.

&lt;/p&gt;&lt;p&gt;
For over a decade, Tecan has supported customers in India through its</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Tecan+Establishes+Direct+Sales+and+Specialist+Lab+Automation+Service+Operations+in+India/26545019.html</guid>
   <pubDate>Tue, 26 May 2026 05:43:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.00222376</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TCGGY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TECN</category>
   	  </item>
  <item>
   <title>Tecan Establishes Direct Sales and Specialist Lab Automation Service Operations in India</title>
   <link>http://www.streetinsider.com/Business+Wire/Tecan+Establishes+Direct+Sales+and+Specialist+Lab+Automation+Service+Operations+in+India/26545019.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;
&lt;i&gt;Strengthening local presence and customer support in a high-growth life sciences market&lt;/i&gt;

&lt;/p&gt;
&lt;p&gt;    MÄNNEDORF, Switzerland--(BUSINESS WIRE)--
Tecan (SIX Swiss Exchange: TECN), a global provider of laboratory automation and solutions, today announced the launch of direct operations in India, including a dedicated local sales and service team based in Gurugram, near New Delhi. The launch, marked with a ribbon-cutting ceremony, is an important milestone in the company’s geographical expansion and reinforces its commitment to serving customers in one of the world’s most dynamic and fastest-growing life sciences markets.

&lt;/p&gt;&lt;p&gt;
For over a decade, Tecan has supported customers in India through its</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Tecan+Establishes+Direct+Sales+and+Specialist+Lab+Automation+Service+Operations+in+India/26545019.html</guid>
   <pubDate>Tue, 26 May 2026 05:43:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.00222376</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TCGGY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TECN</category>
   	  </item>
  <item>
   <title>Tecan Establishes Direct Sales and Specialist Lab Automation Service Operations in India</title>
   <link>http://www.streetinsider.com/Business+Wire/Tecan+Establishes+Direct+Sales+and+Specialist+Lab+Automation+Service+Operations+in+India/26545019.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;
&lt;i&gt;Strengthening local presence and customer support in a high-growth life sciences market&lt;/i&gt;

&lt;/p&gt;
&lt;p&gt;    MÄNNEDORF, Switzerland--(BUSINESS WIRE)--
Tecan (SIX Swiss Exchange: TECN), a global provider of laboratory automation and solutions, today announced the launch of direct operations in India, including a dedicated local sales and service team based in Gurugram, near New Delhi. The launch, marked with a ribbon-cutting ceremony, is an important milestone in the company’s geographical expansion and reinforces its commitment to serving customers in one of the world’s most dynamic and fastest-growing life sciences markets.

&lt;/p&gt;&lt;p&gt;
For over a decade, Tecan has supported customers in India through its</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Tecan+Establishes+Direct+Sales+and+Specialist+Lab+Automation+Service+Operations+in+India/26545019.html</guid>
   <pubDate>Tue, 26 May 2026 05:43:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.00222376</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TCGGY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TECN</category>
   	  </item>
  <item>
   <title>Tecan Establishes Direct Sales and Specialist Lab Automation Service Operations in India</title>
   <link>http://www.streetinsider.com/Business+Wire/Tecan+Establishes+Direct+Sales+and+Specialist+Lab+Automation+Service+Operations+in+India/26545019.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;
&lt;i&gt;Strengthening local presence and customer support in a high-growth life sciences market&lt;/i&gt;

&lt;/p&gt;
&lt;p&gt;    MÄNNEDORF, Switzerland--(BUSINESS WIRE)--
Tecan (SIX Swiss Exchange: TECN), a global provider of laboratory automation and solutions, today announced the launch of direct operations in India, including a dedicated local sales and service team based in Gurugram, near New Delhi. The launch, marked with a ribbon-cutting ceremony, is an important milestone in the company’s geographical expansion and reinforces its commitment to serving customers in one of the world’s most dynamic and fastest-growing life sciences markets.

&lt;/p&gt;&lt;p&gt;
For over a decade, Tecan has supported customers in India through its</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Tecan+Establishes+Direct+Sales+and+Specialist+Lab+Automation+Service+Operations+in+India/26545019.html</guid>
   <pubDate>Tue, 26 May 2026 05:43:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.00222376</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TCGGY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TECN</category>
   	  </item>
  <item>
   <title>BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours</title>
   <link>http://www.streetinsider.com/Press+Releases/BioSkryb+Genomics+and+Tecan+introduce+a+single-cell+multiomics+workflow+for+sequencing-ready+libraries+in+under+ten+hours/24687636.html</link>
   <description>
&lt;ul class=&quot;bwlistdisc&quot;&gt;
&lt;li&gt;
&lt;i&gt;Combines BioSkyrb’s new ResolveOME™ Whole Genome and Transcriptome Single-Cell Core Kit 384-well assay with Uno Single Cell Dispenser™ provided by Tecan in a single workflow&lt;/i&gt;
&lt;/li&gt;
&lt;li&gt;
&lt;i&gt;Enables scalable, high-throughput analysis of hundreds to thousands of single cells, advancing applications in cancer research, drug development and precision medicine&lt;/i&gt;
&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;    DURHAM, N.C. &amp;amp; MÄNNEDORF, Switzerland--(BUSINESS WIRE)--
BioSkryb Genomics and Tecan Group (SIX Swiss Exchange: TECN), today introduced a high-throughput single-cell workflow, combining BioSkryb’s 384-well format of the ResolveOME™ Whole Genome and Transcriptome Single-Cell Core Kit with the Uno Single Cell Dispenser™, provided by Tecan. The integrated solution enables parallel high-resolution analysis of</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/BioSkryb+Genomics+and+Tecan+introduce+a+single-cell+multiomics+workflow+for+sequencing-ready+libraries+in+under+ten+hours/24687636.html</guid>
   <pubDate>Fri, 25 Apr 2025 10:44:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.38055885</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00222376</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01691593</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TCGGY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TECN</category>
   	  </item>
  <item>
   <title>BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours</title>
   <link>http://www.streetinsider.com/Press+Releases/BioSkryb+Genomics+and+Tecan+introduce+a+single-cell+multiomics+workflow+for+sequencing-ready+libraries+in+under+ten+hours/24687636.html</link>
   <description>
&lt;ul class=&quot;bwlistdisc&quot;&gt;
&lt;li&gt;
&lt;i&gt;Combines BioSkyrb’s new ResolveOME™ Whole Genome and Transcriptome Single-Cell Core Kit 384-well assay with Uno Single Cell Dispenser™ provided by Tecan in a single workflow&lt;/i&gt;
&lt;/li&gt;
&lt;li&gt;
&lt;i&gt;Enables scalable, high-throughput analysis of hundreds to thousands of single cells, advancing applications in cancer research, drug development and precision medicine&lt;/i&gt;
&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;    DURHAM, N.C. &amp;amp; MÄNNEDORF, Switzerland--(BUSINESS WIRE)--
BioSkryb Genomics and Tecan Group (SIX Swiss Exchange: TECN), today introduced a high-throughput single-cell workflow, combining BioSkryb’s 384-well format of the ResolveOME™ Whole Genome and Transcriptome Single-Cell Core Kit with the Uno Single Cell Dispenser™, provided by Tecan. The integrated solution enables parallel high-resolution analysis of</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/BioSkryb+Genomics+and+Tecan+introduce+a+single-cell+multiomics+workflow+for+sequencing-ready+libraries+in+under+ten+hours/24687636.html</guid>
   <pubDate>Fri, 25 Apr 2025 10:44:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.38055885</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00222376</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01691593</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TCGGY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TECN</category>
   	  </item>
  <item>
   <title>BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours</title>
   <link>http://www.streetinsider.com/Press+Releases/BioSkryb+Genomics+and+Tecan+introduce+a+single-cell+multiomics+workflow+for+sequencing-ready+libraries+in+under+ten+hours/24687636.html</link>
   <description>
&lt;ul class=&quot;bwlistdisc&quot;&gt;
&lt;li&gt;
&lt;i&gt;Combines BioSkyrb’s new ResolveOME™ Whole Genome and Transcriptome Single-Cell Core Kit 384-well assay with Uno Single Cell Dispenser™ provided by Tecan in a single workflow&lt;/i&gt;
&lt;/li&gt;
&lt;li&gt;
&lt;i&gt;Enables scalable, high-throughput analysis of hundreds to thousands of single cells, advancing applications in cancer research, drug development and precision medicine&lt;/i&gt;
&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;    DURHAM, N.C. &amp;amp; MÄNNEDORF, Switzerland--(BUSINESS WIRE)--
BioSkryb Genomics and Tecan Group (SIX Swiss Exchange: TECN), today introduced a high-throughput single-cell workflow, combining BioSkryb’s 384-well format of the ResolveOME™ Whole Genome and Transcriptome Single-Cell Core Kit with the Uno Single Cell Dispenser™, provided by Tecan. The integrated solution enables parallel high-resolution analysis of</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/BioSkryb+Genomics+and+Tecan+introduce+a+single-cell+multiomics+workflow+for+sequencing-ready+libraries+in+under+ten+hours/24687636.html</guid>
   <pubDate>Fri, 25 Apr 2025 10:44:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.38055885</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00222376</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01691593</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TCGGY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TECN</category>
   	  </item>
  <item>
   <title>BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours</title>
   <link>http://www.streetinsider.com/Press+Releases/BioSkryb+Genomics+and+Tecan+introduce+a+single-cell+multiomics+workflow+for+sequencing-ready+libraries+in+under+ten+hours/24687636.html</link>
   <description>
&lt;ul class=&quot;bwlistdisc&quot;&gt;
&lt;li&gt;
&lt;i&gt;Combines BioSkyrb’s new ResolveOME™ Whole Genome and Transcriptome Single-Cell Core Kit 384-well assay with Uno Single Cell Dispenser™ provided by Tecan in a single workflow&lt;/i&gt;
&lt;/li&gt;
&lt;li&gt;
&lt;i&gt;Enables scalable, high-throughput analysis of hundreds to thousands of single cells, advancing applications in cancer research, drug development and precision medicine&lt;/i&gt;
&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;    DURHAM, N.C. &amp;amp; MÄNNEDORF, Switzerland--(BUSINESS WIRE)--
BioSkryb Genomics and Tecan Group (SIX Swiss Exchange: TECN), today introduced a high-throughput single-cell workflow, combining BioSkryb’s 384-well format of the ResolveOME™ Whole Genome and Transcriptome Single-Cell Core Kit with the Uno Single Cell Dispenser™, provided by Tecan. The integrated solution enables parallel high-resolution analysis of</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/BioSkryb+Genomics+and+Tecan+introduce+a+single-cell+multiomics+workflow+for+sequencing-ready+libraries+in+under+ten+hours/24687636.html</guid>
   <pubDate>Fri, 25 Apr 2025 10:44:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.38055885</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00222376</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01691593</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TCGGY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TECN</category>
   	  </item>
  <item>
   <title>BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours</title>
   <link>http://www.streetinsider.com/Press+Releases/BioSkryb+Genomics+and+Tecan+introduce+a+single-cell+multiomics+workflow+for+sequencing-ready+libraries+in+under+ten+hours/24687636.html</link>
   <description>
&lt;ul class=&quot;bwlistdisc&quot;&gt;
&lt;li&gt;
&lt;i&gt;Combines BioSkyrb’s new ResolveOME™ Whole Genome and Transcriptome Single-Cell Core Kit 384-well assay with Uno Single Cell Dispenser™ provided by Tecan in a single workflow&lt;/i&gt;
&lt;/li&gt;
&lt;li&gt;
&lt;i&gt;Enables scalable, high-throughput analysis of hundreds to thousands of single cells, advancing applications in cancer research, drug development and precision medicine&lt;/i&gt;
&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;    DURHAM, N.C. &amp;amp; MÄNNEDORF, Switzerland--(BUSINESS WIRE)--
BioSkryb Genomics and Tecan Group (SIX Swiss Exchange: TECN), today introduced a high-throughput single-cell workflow, combining BioSkryb’s 384-well format of the ResolveOME™ Whole Genome and Transcriptome Single-Cell Core Kit with the Uno Single Cell Dispenser™, provided by Tecan. The integrated solution enables parallel high-resolution analysis of</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/BioSkryb+Genomics+and+Tecan+introduce+a+single-cell+multiomics+workflow+for+sequencing-ready+libraries+in+under+ten+hours/24687636.html</guid>
   <pubDate>Fri, 25 Apr 2025 10:44:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.38055885</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00222376</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01691593</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TCGGY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TECN</category>
   	  </item>
  <item>
   <title>BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours</title>
   <link>http://www.streetinsider.com/Business+Wire/BioSkryb+Genomics+and+Tecan+introduce+a+single-cell+multiomics+workflow+for+sequencing-ready+libraries+in+under+ten+hours/24687636.html</link>
   <description>
&lt;ul class=&quot;bwlistdisc&quot;&gt;
&lt;li&gt;
&lt;i&gt;Combines BioSkyrb’s new ResolveOME™ Whole Genome and Transcriptome Single-Cell Core Kit 384-well assay with Uno Single Cell Dispenser™ provided by Tecan in a single workflow&lt;/i&gt;
&lt;/li&gt;
&lt;li&gt;
&lt;i&gt;Enables scalable, high-throughput analysis of hundreds to thousands of single cells, advancing applications in cancer research, drug development and precision medicine&lt;/i&gt;
&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;    DURHAM, N.C. &amp;amp; MÄNNEDORF, Switzerland--(BUSINESS WIRE)--
BioSkryb Genomics and Tecan Group (SIX Swiss Exchange: TECN), today introduced a high-throughput single-cell workflow, combining BioSkryb’s 384-well format of the ResolveOME™ Whole Genome and Transcriptome Single-Cell Core Kit with the Uno Single Cell Dispenser™, provided by Tecan. The integrated solution enables parallel high-resolution analysis of</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/BioSkryb+Genomics+and+Tecan+introduce+a+single-cell+multiomics+workflow+for+sequencing-ready+libraries+in+under+ten+hours/24687636.html</guid>
   <pubDate>Fri, 25 Apr 2025 10:44:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.38055885</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00222376</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01691593</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TCGGY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TECN</category>
   	  </item>
  <item>
   <title>BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours</title>
   <link>http://www.streetinsider.com/Business+Wire/BioSkryb+Genomics+and+Tecan+introduce+a+single-cell+multiomics+workflow+for+sequencing-ready+libraries+in+under+ten+hours/24687636.html</link>
   <description>
&lt;ul class=&quot;bwlistdisc&quot;&gt;
&lt;li&gt;
&lt;i&gt;Combines BioSkyrb’s new ResolveOME™ Whole Genome and Transcriptome Single-Cell Core Kit 384-well assay with Uno Single Cell Dispenser™ provided by Tecan in a single workflow&lt;/i&gt;
&lt;/li&gt;
&lt;li&gt;
&lt;i&gt;Enables scalable, high-throughput analysis of hundreds to thousands of single cells, advancing applications in cancer research, drug development and precision medicine&lt;/i&gt;
&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;    DURHAM, N.C. &amp;amp; MÄNNEDORF, Switzerland--(BUSINESS WIRE)--
BioSkryb Genomics and Tecan Group (SIX Swiss Exchange: TECN), today introduced a high-throughput single-cell workflow, combining BioSkryb’s 384-well format of the ResolveOME™ Whole Genome and Transcriptome Single-Cell Core Kit with the Uno Single Cell Dispenser™, provided by Tecan. The integrated solution enables parallel high-resolution analysis of</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/BioSkryb+Genomics+and+Tecan+introduce+a+single-cell+multiomics+workflow+for+sequencing-ready+libraries+in+under+ten+hours/24687636.html</guid>
   <pubDate>Fri, 25 Apr 2025 10:44:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.38055885</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00222376</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01691593</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TCGGY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TECN</category>
   	  </item>
  <item>
   <title>BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours</title>
   <link>http://www.streetinsider.com/Business+Wire/BioSkryb+Genomics+and+Tecan+introduce+a+single-cell+multiomics+workflow+for+sequencing-ready+libraries+in+under+ten+hours/24687636.html</link>
   <description>
&lt;ul class=&quot;bwlistdisc&quot;&gt;
&lt;li&gt;
&lt;i&gt;Combines BioSkyrb’s new ResolveOME™ Whole Genome and Transcriptome Single-Cell Core Kit 384-well assay with Uno Single Cell Dispenser™ provided by Tecan in a single workflow&lt;/i&gt;
&lt;/li&gt;
&lt;li&gt;
&lt;i&gt;Enables scalable, high-throughput analysis of hundreds to thousands of single cells, advancing applications in cancer research, drug development and precision medicine&lt;/i&gt;
&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;    DURHAM, N.C. &amp;amp; MÄNNEDORF, Switzerland--(BUSINESS WIRE)--
BioSkryb Genomics and Tecan Group (SIX Swiss Exchange: TECN), today introduced a high-throughput single-cell workflow, combining BioSkryb’s 384-well format of the ResolveOME™ Whole Genome and Transcriptome Single-Cell Core Kit with the Uno Single Cell Dispenser™, provided by Tecan. The integrated solution enables parallel high-resolution analysis of</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/BioSkryb+Genomics+and+Tecan+introduce+a+single-cell+multiomics+workflow+for+sequencing-ready+libraries+in+under+ten+hours/24687636.html</guid>
   <pubDate>Fri, 25 Apr 2025 10:44:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.38055885</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00222376</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01691593</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TCGGY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TECN</category>
   	  </item>
  <item>
   <title>BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours</title>
   <link>http://www.streetinsider.com/Business+Wire/BioSkryb+Genomics+and+Tecan+introduce+a+single-cell+multiomics+workflow+for+sequencing-ready+libraries+in+under+ten+hours/24687636.html</link>
   <description>
&lt;ul class=&quot;bwlistdisc&quot;&gt;
&lt;li&gt;
&lt;i&gt;Combines BioSkyrb’s new ResolveOME™ Whole Genome and Transcriptome Single-Cell Core Kit 384-well assay with Uno Single Cell Dispenser™ provided by Tecan in a single workflow&lt;/i&gt;
&lt;/li&gt;
&lt;li&gt;
&lt;i&gt;Enables scalable, high-throughput analysis of hundreds to thousands of single cells, advancing applications in cancer research, drug development and precision medicine&lt;/i&gt;
&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;    DURHAM, N.C. &amp;amp; MÄNNEDORF, Switzerland--(BUSINESS WIRE)--
BioSkryb Genomics and Tecan Group (SIX Swiss Exchange: TECN), today introduced a high-throughput single-cell workflow, combining BioSkryb’s 384-well format of the ResolveOME™ Whole Genome and Transcriptome Single-Cell Core Kit with the Uno Single Cell Dispenser™, provided by Tecan. The integrated solution enables parallel high-resolution analysis of</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/BioSkryb+Genomics+and+Tecan+introduce+a+single-cell+multiomics+workflow+for+sequencing-ready+libraries+in+under+ten+hours/24687636.html</guid>
   <pubDate>Fri, 25 Apr 2025 10:44:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.38055885</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00222376</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01691593</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TCGGY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TECN</category>
   	  </item>
  <item>
   <title>BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours</title>
   <link>http://www.streetinsider.com/Business+Wire/BioSkryb+Genomics+and+Tecan+introduce+a+single-cell+multiomics+workflow+for+sequencing-ready+libraries+in+under+ten+hours/24687636.html</link>
   <description>
&lt;ul class=&quot;bwlistdisc&quot;&gt;
&lt;li&gt;
&lt;i&gt;Combines BioSkyrb’s new ResolveOME™ Whole Genome and Transcriptome Single-Cell Core Kit 384-well assay with Uno Single Cell Dispenser™ provided by Tecan in a single workflow&lt;/i&gt;
&lt;/li&gt;
&lt;li&gt;
&lt;i&gt;Enables scalable, high-throughput analysis of hundreds to thousands of single cells, advancing applications in cancer research, drug development and precision medicine&lt;/i&gt;
&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;    DURHAM, N.C. &amp;amp; MÄNNEDORF, Switzerland--(BUSINESS WIRE)--
BioSkryb Genomics and Tecan Group (SIX Swiss Exchange: TECN), today introduced a high-throughput single-cell workflow, combining BioSkryb’s 384-well format of the ResolveOME™ Whole Genome and Transcriptome Single-Cell Core Kit with the Uno Single Cell Dispenser™, provided by Tecan. The integrated solution enables parallel high-resolution analysis of</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/BioSkryb+Genomics+and+Tecan+introduce+a+single-cell+multiomics+workflow+for+sequencing-ready+libraries+in+under+ten+hours/24687636.html</guid>
   <pubDate>Fri, 25 Apr 2025 10:44:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.38055885</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00222376</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01691593</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TCGGY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TECN</category>
   	  </item>
  <item>
   <title>Tecan Expands Portfolio for Specialty Diagnostics With an Asset Purchase Relating to Certain ELISA Kits</title>
   <link>http://www.streetinsider.com/Press+Releases/Tecan+Expands+Portfolio+for+Specialty+Diagnostics+With+an+Asset+Purchase+Relating+to+Certain+ELISA+Kits/24596396.html</link>
   <description>
&lt;p&gt;    MÄNNEDORF, Switzerland--(BUSINESS WIRE)--
Tecan Group (SIX Swiss Exchange: TECN) today announced an agreement to acquire certain assets relating to key ELISA immunoassay products from Cisbio Bioassays SAS, a subsidiary of the global life sciences and diagnostics company, Revvity Inc. The asset purchase includes the manufacturing process of four ELISA kits – two &lt;i&gt;in vitro&lt;/i&gt; diagnostic (IVD) products for specialty diagnostics and disease monitoring, and two research-use-only (RUO) kits.
&lt;/p&gt;&lt;p&gt;
To ensure uninterrupted availability of these four ELISA kits until completion of the asset transfer, IBL International GmbH, a Tecan company, has signed a Master Distributorship Agreement with Cisbio Bioassays</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Tecan+Expands+Portfolio+for+Specialty+Diagnostics+With+an+Asset+Purchase+Relating+to+Certain+ELISA+Kits/24596396.html</guid>
   <pubDate>Thu, 03 Apr 2025 11:45:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.38055885</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00222376</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01691593</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TCGGY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TECN</category>
   	  </item>
  <item>
   <title>Tecan Expands Portfolio for Specialty Diagnostics With an Asset Purchase Relating to Certain ELISA Kits</title>
   <link>http://www.streetinsider.com/Press+Releases/Tecan+Expands+Portfolio+for+Specialty+Diagnostics+With+an+Asset+Purchase+Relating+to+Certain+ELISA+Kits/24596396.html</link>
   <description>
&lt;p&gt;    MÄNNEDORF, Switzerland--(BUSINESS WIRE)--
Tecan Group (SIX Swiss Exchange: TECN) today announced an agreement to acquire certain assets relating to key ELISA immunoassay products from Cisbio Bioassays SAS, a subsidiary of the global life sciences and diagnostics company, Revvity Inc. The asset purchase includes the manufacturing process of four ELISA kits – two &lt;i&gt;in vitro&lt;/i&gt; diagnostic (IVD) products for specialty diagnostics and disease monitoring, and two research-use-only (RUO) kits.
&lt;/p&gt;&lt;p&gt;
To ensure uninterrupted availability of these four ELISA kits until completion of the asset transfer, IBL International GmbH, a Tecan company, has signed a Master Distributorship Agreement with Cisbio Bioassays</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Tecan+Expands+Portfolio+for+Specialty+Diagnostics+With+an+Asset+Purchase+Relating+to+Certain+ELISA+Kits/24596396.html</guid>
   <pubDate>Thu, 03 Apr 2025 11:45:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.38055885</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00222376</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01691593</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TCGGY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TECN</category>
   	  </item>
  <item>
   <title>Tecan Expands Portfolio for Specialty Diagnostics With an Asset Purchase Relating to Certain ELISA Kits</title>
   <link>http://www.streetinsider.com/Press+Releases/Tecan+Expands+Portfolio+for+Specialty+Diagnostics+With+an+Asset+Purchase+Relating+to+Certain+ELISA+Kits/24596396.html</link>
   <description>
&lt;p&gt;    MÄNNEDORF, Switzerland--(BUSINESS WIRE)--
Tecan Group (SIX Swiss Exchange: TECN) today announced an agreement to acquire certain assets relating to key ELISA immunoassay products from Cisbio Bioassays SAS, a subsidiary of the global life sciences and diagnostics company, Revvity Inc. The asset purchase includes the manufacturing process of four ELISA kits – two &lt;i&gt;in vitro&lt;/i&gt; diagnostic (IVD) products for specialty diagnostics and disease monitoring, and two research-use-only (RUO) kits.
&lt;/p&gt;&lt;p&gt;
To ensure uninterrupted availability of these four ELISA kits until completion of the asset transfer, IBL International GmbH, a Tecan company, has signed a Master Distributorship Agreement with Cisbio Bioassays</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Tecan+Expands+Portfolio+for+Specialty+Diagnostics+With+an+Asset+Purchase+Relating+to+Certain+ELISA+Kits/24596396.html</guid>
   <pubDate>Thu, 03 Apr 2025 11:45:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.38055885</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00222376</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01691593</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TCGGY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TECN</category>
   	  </item>
 </channel>
</rss>
